Probes and targets of DNA methylation and demethylation in drug development

Barsam Mirfattah, Jason Herring, Hui Tang, Kangling Zhang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

DNA methylation and demethylation is part of the essential biological processes regulating gene expression in normal cell development. Abnormal methylation status of specific genes and their irregularly translated proteins are normally associated with certain kinds of diseases or cancer. The rapid development of innovative DNA methylation mapping techniques provides a better understanding of DNA methylation pattern and its mechanisms in the human genome and its correlation with numerous diseases. These new techniques can lead us to develop new epigenetic medications, such as DNA methyltransferase inhibitors. As part of the approaches to probe DNA methylation and evaluate the effects of epigenetic therapy, mass spectrometry has been taking an important role in the identification, validation, and quantification of DNA methylation and demethylation. In this review, we will briefly summarize the current breadth of knowledge on the topic of DNA methylation and its occurrence in diseases, DNA methylation drugs, and mass spectrometry based approaches used to study DNA methylation.

Original languageEnglish (US)
Pages (from-to)1727-1740
Number of pages14
JournalCurrent Topics in Medicinal Chemistry
Volume17
Issue number15
DOIs
StatePublished - Jun 1 2017

Fingerprint

DNA Methylation
Pharmaceutical Preparations
Epigenomics
Mass Spectrometry
Biological Phenomena
Methyltransferases
Human Genome
Methylation
Gene Expression
DNA
Genes

Keywords

  • Cancer
  • DNA methylation
  • DNA methyltransferase inhibitor (DNMTi) drugs
  • Mass spectrometry

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Probes and targets of DNA methylation and demethylation in drug development. / Mirfattah, Barsam; Herring, Jason; Tang, Hui; Zhang, Kangling.

In: Current Topics in Medicinal Chemistry, Vol. 17, No. 15, 01.06.2017, p. 1727-1740.

Research output: Contribution to journalArticle

Mirfattah, Barsam ; Herring, Jason ; Tang, Hui ; Zhang, Kangling. / Probes and targets of DNA methylation and demethylation in drug development. In: Current Topics in Medicinal Chemistry. 2017 ; Vol. 17, No. 15. pp. 1727-1740.
@article{251b850768f5429db078a303d8131169,
title = "Probes and targets of DNA methylation and demethylation in drug development",
abstract = "DNA methylation and demethylation is part of the essential biological processes regulating gene expression in normal cell development. Abnormal methylation status of specific genes and their irregularly translated proteins are normally associated with certain kinds of diseases or cancer. The rapid development of innovative DNA methylation mapping techniques provides a better understanding of DNA methylation pattern and its mechanisms in the human genome and its correlation with numerous diseases. These new techniques can lead us to develop new epigenetic medications, such as DNA methyltransferase inhibitors. As part of the approaches to probe DNA methylation and evaluate the effects of epigenetic therapy, mass spectrometry has been taking an important role in the identification, validation, and quantification of DNA methylation and demethylation. In this review, we will briefly summarize the current breadth of knowledge on the topic of DNA methylation and its occurrence in diseases, DNA methylation drugs, and mass spectrometry based approaches used to study DNA methylation.",
keywords = "Cancer, DNA methylation, DNA methyltransferase inhibitor (DNMTi) drugs, Mass spectrometry",
author = "Barsam Mirfattah and Jason Herring and Hui Tang and Kangling Zhang",
year = "2017",
month = "6",
day = "1",
doi = "10.2174/1568026617666161116143828",
language = "English (US)",
volume = "17",
pages = "1727--1740",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "15",

}

TY - JOUR

T1 - Probes and targets of DNA methylation and demethylation in drug development

AU - Mirfattah, Barsam

AU - Herring, Jason

AU - Tang, Hui

AU - Zhang, Kangling

PY - 2017/6/1

Y1 - 2017/6/1

N2 - DNA methylation and demethylation is part of the essential biological processes regulating gene expression in normal cell development. Abnormal methylation status of specific genes and their irregularly translated proteins are normally associated with certain kinds of diseases or cancer. The rapid development of innovative DNA methylation mapping techniques provides a better understanding of DNA methylation pattern and its mechanisms in the human genome and its correlation with numerous diseases. These new techniques can lead us to develop new epigenetic medications, such as DNA methyltransferase inhibitors. As part of the approaches to probe DNA methylation and evaluate the effects of epigenetic therapy, mass spectrometry has been taking an important role in the identification, validation, and quantification of DNA methylation and demethylation. In this review, we will briefly summarize the current breadth of knowledge on the topic of DNA methylation and its occurrence in diseases, DNA methylation drugs, and mass spectrometry based approaches used to study DNA methylation.

AB - DNA methylation and demethylation is part of the essential biological processes regulating gene expression in normal cell development. Abnormal methylation status of specific genes and their irregularly translated proteins are normally associated with certain kinds of diseases or cancer. The rapid development of innovative DNA methylation mapping techniques provides a better understanding of DNA methylation pattern and its mechanisms in the human genome and its correlation with numerous diseases. These new techniques can lead us to develop new epigenetic medications, such as DNA methyltransferase inhibitors. As part of the approaches to probe DNA methylation and evaluate the effects of epigenetic therapy, mass spectrometry has been taking an important role in the identification, validation, and quantification of DNA methylation and demethylation. In this review, we will briefly summarize the current breadth of knowledge on the topic of DNA methylation and its occurrence in diseases, DNA methylation drugs, and mass spectrometry based approaches used to study DNA methylation.

KW - Cancer

KW - DNA methylation

KW - DNA methyltransferase inhibitor (DNMTi) drugs

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=85020861551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020861551&partnerID=8YFLogxK

U2 - 10.2174/1568026617666161116143828

DO - 10.2174/1568026617666161116143828

M3 - Article

VL - 17

SP - 1727

EP - 1740

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 15

ER -